Novacyt S.A.
NVYTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.05 | -0.02 | 0.25 |
| FCF Yield | -31.11% | -62.03% | -29.54% | 4.50% |
| EV / EBITDA | -0.49 | -0.60 | 3.27 | -37.62 |
| Quality | ||||
| ROIC | -55.81% | -27.24% | -15.67% | -0.93% |
| Gross Margin | 163.39% | 32.21% | 27.31% | 30.99% |
| Cash Conversion Ratio | 0.22 | 0.88 | 0.53 | -1.61 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.29% | -50.55% | -57.66% | 104.65% |
| Free Cash Flow Growth | 57.10% | -81.42% | -222.06% | -88.62% |
| Safety | ||||
| Net Debt / EBITDA | 0.54 | 1.66 | 7.37 | 23.80 |
| Interest Coverage | -7.29 | -43.28 | -33.95 | -5.72 |
| Efficiency | ||||
| Inventory Turnover | -5.48 | 2.60 | 5.05 | 5.77 |
| Cash Conversion Cycle | 16.04 | 899.71 | 65.61 | 192.45 |